Hydroxyurea remains effective over the long term among children with sickle cell disease, real-world data suggested. The average time on hydroxyurea was 5 years, with many children on the therapy for ...

SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in patients with hemoglobin SC, a milder form of sickle cell disease (SCD), a ...

Ahmar U. Zaidi, MD: As far as preventive therapies go, hydroxyurea is the mainstay of therapy in sickle cell disease. And hydroxyurea is quite an interesting drug that has been studied very ...

Fewer ED visits per year and fewer hospital days per year seen in association with hydroxyurea use. HealthDay News — For children with sickle cell anemia (SCA), hydroxyurea has sustained clinical ...

Medunik USA (member of Duchesnay Pharmaceutical Group) is pleased to announce that government coverage of Siklos® (hydroxyurea, HU) under State Medicaid programs is now available in 19 states. Siklos ...

Recently reported results from Hydroxyurea Study of Long-Term Effects (HUSTLE) support the use of hydroxyurea in children, and indicate that a preferred dosing strategy should target an HbF endpoint ...

Please provide your email address to receive an email when new articles are posted on . Toxicity on spermatogenesis may not be a major concern for boys with severe sickle cell disease who require ...

Manage your stage 3 ET diagnosis with this guide on high-risk treatments, side effects and new NCCN-preferred options to empower your next visit. While essential thrombocythemia (ET) is classified as ...

Clinical research led by Indiana University School of Medicine investigators and their collaborators in Uganda has revealed that hydroxyurea significantly reduces infections in children with sickle ...

Please provide your email address to receive an email when new articles are posted on . Despite it being the standard of care for treating vasocclusive disease associated with sickle cell disease, ...

A 73-year-old man with a history of chronic myelogenous leukemia presented with multiple ulcers on both legs (Figure 1). The ulcers were extremely painful. The patient had no history of diabetes or ...